In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, ...

A mass rollout of weight loss injections begins across the NHS on Monday, with GPs able to prescribe Mounjaro for the first ...

However, if you're planning to ask your GP to prescribe it, are you actually eligible and do you meet the very specific ...

Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of acute and chronic pancreatitis among people taking them, figures from the UK ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

Prescriptions for tirzepatide injections will not be available from GP surgeries or pharmacies in East and North Yorkshire – ...

At 12 weeks, weight loss ranged from 2.6% to 11.3%, compared to a gain of 0.2% in the placebo group. Guggenheim analysts were ...